Ensuring Patient Safety

No more knee replacement surgery? We can now re-grow knee cartilage with a single injection. When knee cartilage wears away with age, every step becomes painful. This affects 1 in 5 American adults and costs $65 billion a year in medical bills. Dr. Nidhi Bhutani and her team at Stanford Medicine might have solved this problem forever. Here's how 👇 ▶ They found a molecule that blocks 15-PGDH This protein builds up in your knees and wears away cartilage. The team identified a compound that stops this process. They injected it into old mice with worn-out knees. The cartilage grew back - thick and strong. ▶ It stopped arthritis before it started Half of all people who tear their ACL develop arthritis. When tested in mice with torn ligaments, the injection prevented arthritis from developing. ▶ It worked on human tissue They tested it on actual knee tissue from patients undergoing knee replacements. After one week, the cartilage started re-growing.  Not just healing. Re-growing. ▶ A pill version is already in clinical trials An oral version of this treatment is now being tested on humans. If it works, it could eliminate the need for knee replacements entirely - a surgery performed over 1 million times a year in the US alone. I believe this is the kind of breakthrough healthcare needs. Not just managing decline, but reversing it. Because the alternative isn't just surgery. It's millions of people losing mobility, independence, and quality of life because their bodies aged. Do you think this will eventually replace joint replacement surgeries? #entrepreneurship #healthtech #innovation

Integrated brain training is a real game-changer for ACL rehab. 🤔 In sports, athletes perform in dynamic, unpredictable settings, making split-second decisions while executing complex movements. That's a far cry from the controlled environment of typical rehab sessions. 💡 Rehab focuses on task-oriented exercises and internal feedback, but it might be missing the mark. From recent research it even seems that classic rehabilitation induces as much, if not more, of the neuroplasticity than the injury itself, increasing the risk of re-injury (Grooms, in press).   🏋️♀️ There’s a need for an implicit and dual-task approach in ACL rehab, starting from the early stages. The video highlights the integration of this approach into ACL rehab.   🔴 SL squat right leg; Pass left; Count -1.  🟢 Step-up right leg; Pass left; Count +1.  🟣 SL RDL right leg; Count -2.  🔵 SL squat left; Header.  🟡 Step-up left leg; Header; Count +2.  🩵 SL RDL left leg.   1️⃣ Neuromuscular deficits and muscle weakness occur at different central nervous system levels (Cortical, subcortical and spinal level) in ACL patients (Tayfur 2020, Bodkin 2019). These deficits in central activation are linked to poor recuperation of quadriceps activation and strength (Criss 2023). These neural deficits not only prevent effective strengthening, but also contribute to secondary injury risk (Capin 2016). Impaired strength and central nervous system excitability persist for months to years after ACL surgery, suggesting the need for integrated brain training during the early stages of ACL rehab (Kuenze 2015). Traditional concentric exercises cannot overcome the inhibited cortical drive to the muscle and therefore fails to adequately activate muscles and restore neuromuscular control (Lepley 2015).     2️⃣ There's a link between how our brains work and the risk of ACL injuries. Brain activity related to visual, proprioceptive and attentional integration are crucial factors in rehab and prevention of ACL injury (Grooms 2022). Interestingly, athletes with high-risk landing biomechanics following ACL rehab exhibit a brain activation pattern shifted toward increased visual-proprioceptive and spatial processing to organize movement. However, this heightened reliance on attentional and sensory processing for movement coordination might compromise their ability to effectively maintain neuromuscular control in high-pressure sports situations involving opponents or the ball (common scenarios for ACL injuries) (Villa 2020) The current task-oriented rehab methods might actually reinforce these less effective brain activation patterns rather than fixing them. It is paramount to design rehab programs that challenge both the body and the brain, simulating the unpredictable situations athletes face during games. By integrating tasks that require perception, quick decision-making and neuromuscular control, we are able to retrain the brain and reduce the risk of injuries (Chaaban 2023, Grooms 2017). #acl

Pt safety for AI safety... A recent conversation gave me one of those "why aren't we already doing this?" moments. We're spending enormous energy figuring out how to make #AI safe in healthcare. And we should be. The risks are real and likely to get more acute over time as the usage of #AI in Healthcare grows. What I've been wondering about is why we are treating this risk as something unusual...we already have a well-established, well-tested infrastructure for managing risk to patients sitting in every health system in the country. It's our existing #patientsafety experts and systems. When an AI model or algorithm produces an erroneous clinical result, we should treat it with the same rigor and scrutiny we'd apply to any patient-facing technology or process failure. What does that mean? → Report it through your existing event reporting systems → Execute comprehensive root cause and common cause analyses → Discuss findings in M&M conferences and risk management committees → Apply the hierarchy of controls to eliminate or mitigate the risk going forward We don't need to build something new from scratch. We need to redeploy what we've already built — the structures, the processes, the culture of safety — and extend them to cover AI-related risks. The discipline of #PatientSafety has spent decades researching and deploying best practices for how to interrogate system failures without blame and facilitating the redesign of systems and processes to prevent recurrence. That's exactly the muscle we need right now. The tools are already in your organization. Let's use them. My patient safety colleagues...what am I missing? How do we need to adapt our safety infrastructure to meet the AI moment? #HealthcareAI #QualityImprovement #PatientSafety #AI

The most dangerous myth in MedTech? That quality is solely QA’s job. That belief costs companies millions. Think about it: • Remediation • Delayed launches • Damaged reputations The impact is real. Quality is not a department. It is a shared responsibility across product development, operations, leadership, and every function that touches the patient. But here’s the nuance I’ve learned after more than 25 years in biotech, pharmaceuticals, and medical devices: Shared responsibility does not erase individual roles. It clarifies them. Here is how quality ownership should actually be distributed across an organization: 1. What a QA Manager is truly responsible for: • Building and maintaining the QMS • Preparing for FDA, ISO, MDR, IVDR, and MDSAP audits • Leading CAPA management and long-term effectiveness • Overseeing documentation and change control • Ensuring compliance with all regulatory requirements 2. Where companies consistently go wrong: • Expecting QA to catch every defect or oversight • Asking QA to write technical procedures for other departments • Isolating risk management within QA instead of placing it with departmental or process experts • Pushing last-minute compliance cleanups onto QA • Treating quality as the “police” instead of a strategic partner 3. What requires real cross-functional partnership: • Partnering with engineering on strong design controls • Closing CAPAs by fixing systemic issues • Monitoring post-market performance • Improving supplier quality with shared ownership • Helping teams use documentation for safety and consistency QA managers cannot and should not function as quality superheroes. You need an entire organization of quality champions. Here are questions that every team should think about: • Who actually owns design controls? • Is QA guiding or just cleaning up? • Has anyone outside QA had recent compliance training? • Are we fixing root causes or patching symptoms? • Do non-QA teams see how their choices affect audits and patients? Shifting from “quality is their job” to “quality is our job” takes discipline, but the payoff is undeniable: • Higher team alignment • Safer, more reliable products • Stronger relationships with regulators • Faster readiness for certification and market entry The results speak for themselves when quality becomes part of the culture, not just the checklist. P.S. If you asked me how to explain to a CEO that QA is not a document-writing silo, I’d say this: Quality protects the patient, the brand, and the business. Its value comes from partnership, not paperwork. As someone who has spent decades in biotech and MedTech quality and compliance, I continue to help teams strengthen this mindset. I’m also opening new training sessions on ISO certification, internal auditing, and compliance fundamentals for cross-functional teams, ensuring compliance with ISO, FDA, and any other applicable requirements. Let me know if you’d like the details.

Quality Control department and it's staff is the face of the company 💯 QCM is the main responsible person to maintain the quality in the department. He must be trained and vigilant. Otherwise, the nation suffers a lot. Quality control cleaning is extremely critical in the pharmaceutical industry. In fact, it's a crucial aspect of ensuring the safety, efficacy, and quality of pharmaceutical products. Here are some reasons why quality control cleaning is so important: 1. Pharmaceutical products can be contaminated with dust, dirt, bacteria, and other microorganisms, which can affect their safety and efficacy. Quality control cleaning helps prevent contamination and ensures a clean environment for production. 2. Pharmaceutical companies must comply with strict regulations and guidelines, such as those set by the FDA, WHO, and EU GMP. Quality control cleaning is essential to meet these regulatory requirements. 3. Cleaning and sanitation are critical to ensuring the quality of pharmaceutical products. Any residual contaminants or impurities can affect the product's stability, potency, and safety. 4. Ultimately, the goal of quality control cleaning is to ensure the safety of patients who use pharmaceutical products. Contaminated products can cause serious harm or even death, so it's essential to maintain a clean and controlled environment. 5. Quality control cleaning helps prevent cross-contamination between different products, which can be particularly important in facilities that produce multiple products. Some key areas where quality control cleaning is critical in the pharmaceutical industry include: - Cleaning and sanitizing equipment, such as reactors, tanks, and fillers, to prevent contamination and ensure product quality. - Cleaning and sanitizing facilities, including floors, walls, and ceilings, to prevent contamination and maintain a clean environment. - Maintaining clean and controlled air and water systems to prevent contamination and ensure product quality. - Validating cleaning processes to ensure they are effective and consistent. In summary, quality control cleaning is a critical aspect of the pharmaceutical industry, ensuring the safety, efficacy, quality of products, compliance with regulations, and patient safety. #QCdepartmentcleaningsetthecompanypolicy #qcmmustbetrainedenough #donotcompromiseonquality

Pharmaceutical facilities💊🧬 must be designed to be in compliance with relevant company specific standards and regulatory requirements in the areas of GMP and Health, Safety and Environment (HSE). It's two fold in ensuring the Quality of the medicinal product and safety and security of people and assets. Facilities must be designed with the following basic requirements:💡 ✔️ The designated location of buildings and facilities must be appropriate to the processes performed and products handled. ✔The design must permit all necessary cleaning, maintenance and proper access to the process. ✔The design of the building and facility must conform to HSE internal and external requirements. ✔Design documents as a basis for design qualification of the facility (e.g. layout, environmental zoning concepts, room data sheets, etc.) must be provided and kept updated. ✔The design must ensure adequate lighting for the work performed. ✔When required, environmental controls such as temperature and humidity of the production, testing and storage areas must be designed and maintained to ensure the quality of the products and/or materials as well as to ensure the reliability of the equipment. ✔There must be appropriate protection against the entry of pests. ✔The access to production areas must be limited to those working in these areas. There must be measures to prevent unauthorised access. ✔The number of drains must be limited. Where necessary they must be designed appropriately to the environmental zones where they are located. ✔The design must ensure the prevention of mix-up and cross-contamination by means of space, segregation, ventilation and logical workflow for materials and personnel. ✔Services (pipes, lights, etc.) must be designed to facilitate appropriate cleaning and maintenance. ✔Facility surfaces must be smooth, non-particulate shedding, free from cracks, and open joints in all areas where the quality of the products could be compromised and must not present risks of either microbiological or particulate contamination. ✔Facilities must be of a design suitable for their intended purpose. If Highly Active Pharmaceuticals (HAP) are produced, additional protection measures are required. ✔Areas with restricted personnel access must be designed with features that facilitate the supervision of employees working within those areas. ✔Each facility must have appropriate waste disposal system(s). ✔Special provisions, such as localised exhaust systems, must be used in areas where dust or fumes are generated. ✔Special provisions must be made for production, testing and storage of materials and products with special HSE requirements (e.g. penicillins, cephalosporins, hormones, Highly Active Pharmaceuticals, and biologicals). ✔Equipment washing facilities must be suitably designed to ensure that the equipment can be cleaned, handled and stored in a manner that is appropriate for its use. Diagram for illustration purposes only. www.inglasia.com

The core issue facing the Safety and Health (OHS) industry today is the gap between having certifications and possessing genuine safety awareness and passion. While many professionals hold impressive OHS certificates, they often treat safety procedures merely as administrative compliance or a routine task—a job, not a core belief. This transactional view of safety, driven by regulation rather than conviction, diminishes its value, leading to procedural shortcuts and a failure to cultivate a true safety culture, ultimately hindering the goal of zero accidents. To bridge this gap, OHS must transition from being perceived as a burdensome cost or mere paperwork to an intrinsic corporate value. This shift requires emphasizing the "Why" in safety training—connecting procedures to personal stakes, such as going home safely to family. Crucially, it demands visible commitment from Top Management, transforming safety from a standalone add-on into an integrated part of quality, productivity, and operational planning. Only when OHS moves from mandatory compliance to passionate commitment can organizations build a resilient and effective safety mindset.

Every patient deserves a safe transfer — and so do the healthcare workers moving them. Back injuries are one of the leading causes of lost workdays in healthcare. Whether you’re a radiographer, nurse, porter, or physiotherapist, long shifts, heavy lifting and awkward positions during transfers can take a serious toll. During my time in the Middle East, we were regularly trained on back awareness. These sessions focused on proper posture, teamwork and the use of aids to protect staff and patients. Radiographers and nurses will know the value of: Proper log rolling techniques to keep the spine aligned and prevent injury. Roller boards and pat slides to ensure smoother, safer patient transfers. Calling for assistance instead of risking a solo lift. These seemingly small habits make a huge difference in reducing workplace injuries and improving patient comfort. Today I came across a new innovation from China — smart transfer beds that move patients automatically with zero effort. It’s inspiring to see technology stepping in to protect staff while improving patient safety. But while such devices may take time to reach hospitals worldwide, our everyday practices remain the frontline of back safety. As healthcare professionals, protecting our backs is protecting our ability to care for others. 💡 How does your workplace protect staff during patient transfers? 💡 What tools or techniques have you found most helpful? Let’s share our experiences and keep the conversation going. Together, we can make back awareness and safe patient transfers a priority everywhere. #BackAwareness #HealthcareSafety #PatientTransfer #Radiography #Nursing #OccupationalHealth #HealthcareInnovation

𝗘𝗻𝘀𝘂𝗿𝗶𝗻𝗴 𝗣𝗮𝘁𝗶𝗲𝗻𝘁 𝗮𝗻𝗱 𝗖𝗼𝗻𝘀𝘂𝗺𝗲𝗿 𝗦𝗮𝗳𝗲𝘁𝘆 𝗶𝗻 𝘁𝗵𝗲 𝗠𝗲𝗱𝗶𝗰𝗮𝗹 𝗖𝗮𝗻𝗻𝗮𝗯𝗶𝘀 𝗜𝗻𝗱𝘂𝘀𝘁𝗿𝘆 Despite significant growth over the past decade, the medical cannabis industry still faces major challenges in ensuring patient & consumer safety. Contaminated products, inadequate testing, & regulatory gaps persist, posing serious health risks. Contaminants such as bacteria, heavy metals, & pesticides are often found in cannabis products at levels exceeding permissible limits. This ongoing issue highlights the urgent need for stringent standards & consistent enforcement across the industry. 𝙆𝙚𝙮 𝙎𝙩𝙚𝙥𝙨 𝙩𝙤 𝘼𝙙𝙙𝙧𝙚𝙨𝙨 𝙩𝙝𝙚 𝙄𝙨𝙨𝙪𝙚𝙨: 1. Unified Testing Standards: Implementing comprehensive, standardised testing protocols across all jurisdictions to ensure rigorous testing for contaminants. 2. Accreditation and Auditing: Ensuring all testing laboratories are accredited & regularly audited for compliance with industry standards. 3. Transparent Labelling: Mandating transparent labelling of cannabis products, including detailed information on contaminant levels & test results, to empower consumers & build trust. 4. Enhanced Regulatory Oversight: Strengthening regulatory frameworks with strict penalties for non-compliance and regular inspections of cultivation & manufacturing facilities. 5. Education & Training: Providing comprehensive education & training programs for cultivators, manufacturers, & dispensary staff to maintain high safety standards. 𝘼𝙙𝙙𝙧𝙚𝙨𝙨𝙞𝙣𝙜 𝘾𝙤𝙧𝙣𝙚𝙧-𝘾𝙪𝙩𝙩𝙞𝙣𝙜 𝙋𝙧𝙖𝙘𝙩𝙞𝙘𝙚𝙨: • Strengthening Enforcement: Regulatory bodies must be empowered and adequately funded to carry out inspections & enforce compliance. Penalties for violations should be substantial enough to deter non-compliance. • Promoting Best Practices: The industry should promote & incentivise best practices among cultivators & manufacturers through certification programs & peer reviews. • Consumer Awareness: Educating consumers about the importance of product safety & the risks of contaminated cannabis can drive demand for higher-quality products, encouraging the industry to prioritise safety & quality. 𝙇𝙤𝙣𝙜-𝙏𝙚𝙧𝙢 𝘽𝙚𝙣𝙚𝙛𝙞𝙩𝙨: Implementing rigorous safety standards will yield significant long-term benefits: • Improved Health Outcomes: Reducing exposure to harmful contaminants will enhance patient health & well-being. • Increased Consumer Trust: Consistently high-quality, safe products will build consumer trust & loyalty. • Industry Credibility: Adherence to high standards will enhance the credibility & legitimacy of the cannabis industry. • Sustainable Growth: A focus on safety & quality will attract a more diverse consumer base & promote sustainable industry growth. By prioritising patient & consumer safety, the medical cannabis industry can build a trustworthy, credible marketplace, ensuring long-term success & the well-being of all stakeholders. #Safety #QC Picture ©Carl Haffner 2024

There ya have it... A little to close for comfort. A close call, near miss, or accident without injury is easy to shrug off and forget. But there is a danger in brushing off accidents that don’t hurt, harm, or damage. In order to learn from close calls, the incidents must be reported and investigated. Employees need to understand that the purpose of studying near misses is not to punish them or assign blame; it is to improve workplace safety and reduce injuries. Reporting close calls leads to improvements in work areas and job procedures while allowing the correction of unsafe conditions before an injury occurs. Failing to report even a small incident allows hazards to escalate into more serious situations. When a close call happens, it should immediately send up a red warning flag that something was wrong, unplanned, unexpected, and could happen again. The next time it happens, it could result in serious damage, injury, or death.